Novogene Co., Ltd. (SHA:688315)
13.88
+0.66 (4.99%)
Jul 15, 2026, 3:00 PM CST
Novogene Employees
Novogene had 2,225 employees as of December 31, 2025. The number of employees increased by 23 or 1.04% compared to the previous year.
Employees
2,225
Change
23
Growth
1.04%
Revenue / Employee
1.02M CNY
Profits / Employee
73.04K CNY
Market Cap
5.35B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,225 | 23 | 1.04% |
| Jun 30, 2025 | 2,190 | - | - |
| Dec 31, 2024 | 2,202 | 58 | 2.71% |
| Dec 31, 2023 | 2,144 | - | - |
| Dec 31, 2021 | 2,169 | 178 | 8.94% |
| Dec 31, 2020 | 1,991 | -584 | -22.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xiangxue Pharmaceutical | 2,662 |
| R&G PharmaStudies | 2,645 |
| Hefei Lifeon Pharmaceutical | 1,465 |
| PharmaResources (Shanghai) | 1,155 |
| Wuhan Hvsen Biotechnology | 1,133 |
| Wuhan Keqian Biology Co.,Ltd | 950 |
| Shenzhen Weiguang Biological Products | 901 |
| Beijing Konruns Pharmaceutical | 793 |